Effect of vatsadani kwath in gout

Randomised open controlled clinical study to evaluate the efficacy of vatsadani kwath in vatarakta w.s.r to gout - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060357

Enrollment

Registered

2023-11-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M103- Gout due to renal impairment Health Condition 2: M100- Idiopathic gout Health Condition 3: E798- Other disorders of purine and pyrimidine metabolism Health Condition 4: M104- Other secondary gout

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with clinical sign and symptoms specific with Toda ,shoth,daha and Sthabdhata in uttan vatarakta in relation to parva sadhi

Exclusion criteria

Exclusion criteria: 1.Known case of Amavata , Sandhigatvata , SLE. 2.Pregnant and lactating womens.

Design outcomes

Primary

Measure	Time frame
To study the effect of vatsadani kwath in vatarakta on assessment of objective parameters like serum uric acid and subjective parameters like sanditodh sandidaha kandu sfurana shotha stabdatha twak krushnataTimepoint: 1 month	—

Secondary

Measure	Time frame
To reduce the signs & symptoms of vatarakta To study vatarakta in detail according to ayurveda & gout in detail according to modern text Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Yogesh Balaso Gaikwad

Yashwant Ayurvedic College and Post graduate and research centre kodoli

suryakiran_wagh@rediffmail.com9822846910

Outcome results